Product theme

CN EN

Stock code: 002653.SZ

Home

News

Innovation

Pipeline R&D Platforms

Products

Product List Product Topics Pharmacovigilance

Investors

Stock Information Company Announcements Market Data Q&A Investor Hotline

Join Us

Talent Philosophy Careers

About Haisco

About Us Business Presence

GLOBAL

English China

Committed to Becoming the Most Trusted International Pharmaceutical Company

Innovation and quality guide everything we do at Haisco. Our core products protect health and bring the reliability of Chinese-developed medicines to patients worldwide.

Anesthesia and Analgesia

SISHUNING® (Cipepofol Injection)

China's first independently developed Class 1 intravenous anesthetic with global independent intellectual property rights

Learn more

Neurological and Psychiatric System

SIMEINING® (Crisabalin Besilate Capsules)

China's first independently developed Class 1 intravenous anesthetic with global independent intellectual property rights

Learn more

Endocrine System

BEICHANGPING® (Cofrogliptin Tablets)

China's first independently developed Class 1 intravenous anesthetic with global independent intellectual property rights

Learn more

Anesthesia and Analgesia

SISHUJING® (Anrikefon Injection)

The first highly selective peripheral K receptor agonist with analgesic indications in the world.

Learn more

Digestive and Hepatic Diseases

SIFU® (Polyene Phosphatidylcholine Injection)

This is the only liver cell membrane repair injection in China, and it is a proprietary imitation drug developed by Haisco.

Learn more

Oncology

LIBIFU® (Dolasetron Mesylate Injection)

Used to prevent nausea and vomiting caused by initial and repeated cytotoxic chemotherapy (including high-dose cisplatin).

Learn more